[1]
T. Wiatr, P. Chłosta, and M. Chłosta, “α-blocker tailor-made. Prostatic hyperplasia treatment ? safety, efficacy, and patient acceptability”, J EBM, vol. 17, no. 4(65), pp. 487-491, Dec. 2024.